APOE and modulation of Alzheimer's and frontotemporal dementia
- PMID: 15036621
- DOI: 10.1016/j.neulet.2003.11.042
APOE and modulation of Alzheimer's and frontotemporal dementia
Abstract
To investigate the difference in the morphologic expression of frontotemporal dementia (FTD) and Alzheimer's disease (AD) in patients carrying and not carrying the epsilon4 allele of APOE, MR images of 26 controls, 18 AD patients (11 carrying the epsilon4 allele, seven non-carriers), and eight FTD (two carriers, six non-carriers) were compared using voxel by voxel analysis. Greater atrophy was found in the disease-specific regions of the epsilon4 carriers vs the non-carriers at P < 0.05 corrected: medial temporal atrophy was greater in the AD carrying the epsilon4 allele, right ventral striatal atrophy in the FTD carrying the allele. The non-carriers did not have atrophic regions compared to the carriers. The epsilon4 allele of the APOE might modulate the expression of degenerative dementias by enhancing the specific effects of neurodegenerative diseases on the brain.
Similar articles
-
Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.Neuroimage. 2009 Feb 1;44(3):724-8. doi: 10.1016/j.neuroimage.2008.10.003. Epub 2008 Nov 1. Neuroimage. 2009. PMID: 19013250
-
The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia.Ann Neurol. 1998 Jul;44(1):134-8. doi: 10.1002/ana.410440122. Ann Neurol. 1998. PMID: 9667603 Clinical Trial.
-
APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.Neuroimage. 2011 Apr 1;55(3):909-19. doi: 10.1016/j.neuroimage.2010.12.081. Epub 2011 Jan 9. Neuroimage. 2011. PMID: 21224004
-
The effects of APOE-ε4 on the BOLD response.Neurobiol Aging. 2012 Feb;33(2):323-34. doi: 10.1016/j.neurobiolaging.2010.03.009. Epub 2010 Apr 20. Neurobiol Aging. 2012. PMID: 20409610 Review.
-
[Apolipoprotein E typology and dementia].Nervenarzt. 1994 Jul;65(7):492-5. Nervenarzt. 1994. PMID: 7800096 Review. German. No abstract available.
Cited by
-
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.Neuroimage. 2009 Mar;45(1 Suppl):S3-15. doi: 10.1016/j.neuroimage.2008.10.043. Epub 2008 Nov 8. Neuroimage. 2009. PMID: 19041724 Free PMC article.
-
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia.Neurobiol Aging. 2015 Oct;36(10):2904.e13-26. doi: 10.1016/j.neurobiolaging.2015.06.005. Epub 2015 Jun 12. Neurobiol Aging. 2015. PMID: 26154020 Free PMC article.
-
Apolipoprotein E and Alzheimer's disease.Acta Pharm Sin B. 2022 Feb;12(2):496-510. doi: 10.1016/j.apsb.2021.10.002. Epub 2021 Oct 15. Acta Pharm Sin B. 2022. PMID: 35256931 Free PMC article. Review.
-
Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2018-22. doi: 10.1073/pnas.0812697106. Epub 2009 Jan 22. Proc Natl Acad Sci U S A. 2009. PMID: 19164761 Free PMC article.
-
Association between risk polymorphisms for neurodegenerative diseases and cognition in colombian patients with frontotemporal dementia.Front Neurol. 2022 Aug 22;13:675301. doi: 10.3389/fneur.2022.675301. eCollection 2022. Front Neurol. 2022. PMID: 36071893 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous